Return to Biostatistics Ethics Case Studies
(PLEASE NOTE: On the bottom of this page, you will find the case study we are discussing and the name of the contributor.)
This topic: CTSpedia > WebHome > EthicsBiostat > StatEthicsCaseStudies > BiostatEthicsCaseStudy004
Topic revision: 07 Feb 2013, MaryBanach
Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Foswiki? Send feedback
TITLE Case Study: Should statisticians patent?
%COMMENT{type="belowthreadmode"}%BiostatEthicsCaseStudyForm edit
| Title_Biostatistics_Ethics_Case_Study | Should statisticians patent? |
| Name_Case_Contributor | Shelley Hurwitz |
| Deidentified_Material | Yes |
| No_Copyright_Restrictions | Yes |
| Case_Presentation | Statistical methods and study designs can be patented. Dr. David A. Schoenfeld, Harvard Medical School, developed a new clinical trial design, the "Sequential Parallel Design," and considered patenting it. He asked, is patenting a statistical design ethical? Do you think patenting methods will impede or encourage their use? Should patenting be encouraged or discouraged? What are the practical and ethical consequences of patenting and/or using patented methods? (posted with permission) |
| See Also | |
| Disclaimer | The views expressed within CTSpedia are those of the author and must not be taken to represent policy or guidance on the behalf of any organization or institution with which the author is affiliated. |
Topic revision: 07 Feb 2013, MaryBanach
Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors. Ideas, requests, problems regarding Foswiki? Send feedback